News from

News Archive

Every story published by Penn Today—all in one place.
Reset All Filters
21016 Results
Global Research Seminar in Jamaica

Global Research Seminar in Jamaica

This spring, Penn Carey Law students traveled to Kingston, Jamaica, as part of the Global Research Seminar in Reproductive Rights and Justice in Jamaica, led by Professor Dorothy Roberts.

How a free medical telesimulation platform is saving children’s lives
CHOP physicians Elizabeth Sanseau (left) and Vanessa Denny (right) with Kyle Cassidy of the Annenberg Extended Reality Lab (center) demonstrate how modules of Annenberg Hotkeys, a free, openly accessible interactive distance learning platform, are filmed.

CHOP physicians Elizabeth Sanseau (left) and Vanessa Denny (right) with Kyle Cassidy of the Annenberg Extended Reality Lab (center) demonstrate how modules of Annenberg Hotkeys, a free, openly accessible interactive distance learning platform, are filmed.

nocred

How a free medical telesimulation platform is saving children’s lives

A new study on sepsis training in Ghana builds on prior research showing the impact of Annenberg Hotkeys, a free platform developed in 2020. It is being used in other medical settings—and its co-creator sees potential in nonmedical uses.

3 min. read

What happens when an iceberg melts?
An iceberg in Iceland.

Research from Hugo Ulloa, an assistant professor in the Department of Earth & Environmental Science, and Daisuke Noto of Hokkaido University, models how icebergs melt and move in their environments.

(Image: Gabi Musat / 500px via Getty Images)

What happens when an iceberg melts?

With ice balls, lasers, and cameras, School of Arts & Sciences’ Hugo Ulloa recreated a melting iceberg in his lab. This project revealed that icebergs don’t sit passively on the water’s surface but actually release dense, cold water and jet across the surface, churning and mixing everything in their paths.

From Omnia

2 min. read

Fighting oral cancer with bioengineered chewing gum
A latex-gloved hand hoding a petri dish of medical chewing gum.

A bioengineered bean gum from the lab of Penn Dental’s Henry Daniell is found to reduce the levels of three microbes associated with head and neck squamous cell cancer to almost zero, without affecting the beneficial bacteria normally found in the mouth.

(Image: Kevin Monko/Penn Dental Medicine)

Fighting oral cancer with bioengineered chewing gum

Research led by Penn Dental’s Henry Daniell shows that antiviral and antibacterial chewing gums reduce the levels of three microbes linked to worse outcomes in oral cancers, paving the way for more effective and affordable therapies.

2 min. read

Cultivating health through public space

Cultivating health through public space

Catherine Seavitt examines the connections between public space and public health through the lens of ecology, policy, and plant science.

Are your staffing metrics enough? New research on patient falls says maybe not

Are your staffing metrics enough? New research on patient falls says maybe not

A new study from Penn Nursing’s Center for Health Outcomes and Policy Research finds that nurses’ assessments of their staffing adequacy is a more accurate predictor of patient safety on medical surgical units than traditional administrative data, and highlights a critical distinction in how staffing should be measured and managed.

Penn Medicine, CHOP team awarded Breakthrough Prize for developing gene therapy for inherited blindness
Jean Bennett and Albert Maguire

Physician-scientists Jean Bennett and Al Maguire (right and left, respectively, pictured in their home), and Katherine High received the 2026 Breakthrough Prize in Life Sciences for their trailblazing work on the first FDA-approved gene therapy for an inherited condition, which dramatically improves sight in people with a form of blindness called Leber congenital amaurosis.

(Image: Peggy Peterson)

Penn Medicine, CHOP team awarded Breakthrough Prize for developing gene therapy for inherited blindness

Jean Bennett, Albert Maguire, and Katherine High have been honored for their trailblazing work on the first FDA-approved gene therapy for an inherited condition.

From Penn Medicine News , Frank Otto

2 min. read